Hematology News and Research

RSS

Hematology, also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases.

Findings from study of immunotherapy vaccine in prostate cancer patients

Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic disease will be presented by Oregon Health & Science University Cancer Institute researchers.

5 Jun 2007

Medical management of another condition may not lead to early cancer diagnosis

Being in regular contact with healthcare providers because of a chronic illness such as diabetes or heart disease doesn't necessarily mean a person is more likely to have a cancer detected early, according to a study led by Duke University Comprehensive Cancer Center researchers.

5 Jun 2007

C-reactive protein identified as marker for prostate cancer survival

Oregon Health & Science University Cancer Institute researchers have identified a protein that is a strong indicator of survival for men with advanced prostate cancer.

3 Jun 2007

Northwestern University researchers find drug reactions six years earlier than the FDA and drug companies

Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.

30 May 2007

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

New updated results from a pivotal Phase II trial evaluating Revlimid in patients with an incurable blood cancer known as myelodysplastic syndromes (MDS) were presented by Dr. Alan List, from the H. Lee Moffitt Cancer Center & Research Institute, at the 9th International Symposium on MDS currently taking place in Florence, Italy.

18 May 2007

Simple blood test could predict relapse or survival for children and young adults with acute leukemias

A review of young leukemia patients over the past decade has shown that the absolute lymphocyte count (ALC), a measure of normal immune cells found on every complete blood count report, is a powerful predictor of survival for young patients with leukemia.

8 May 2007

Steroidal hormones for contraception in women with sickle cell disease

Hormonal contraceptives are unlikely to predispose women to type 2 diabetes and appear to be safe for those with sickle cell anemia.

4 May 2007

Tarceva extends life of patients with pancreatic cancer

New results published by the Journal of Clinical Oncology show that adding Tarceva (erlotinib) to gemcitabine chemotherapy significantly improves survival by 22 percent in patients with advanced pancreatic cancer.

27 Apr 2007

Abbott and signs contract with Premier for diagnostic tests

Abbott has announced that it has signed a new group purchasing agreement with Premier, Inc., a leading healthcare alliance, for a broad line of the company's diagnostic products.

17 Apr 2007

Gleevec shows great promise in preventing cancer recurrence

Gleevec, a pill developed in conjunction with the Oregon Health & Science University Cancer Institute is again showing excellent results in preventing a cancer recurrence.

15 Apr 2007

Physical, emotional burden of breast cancer lingers for older survivors

Surviving breast cancer is both a physical and an emotional ordeal, but the consensus among researchers is that life generally returns to normal for most women within two years of completing treatment.

7 Apr 2007

Method for making new molecules based on flavonoids - implications for cancer therapeutics

You've heard of them -- the good-for-your-health compounds found in plants that we enjoy in red wine, dark chocolate, green tea and citrus fruits.

5 Apr 2007

Bayer Healthcare Pharmaceuticals launches in the U.S.

Bayer HealthCare Pharmaceuticals Inc. today announced its official U.S. launch. The new company incorporates the former Berlex Inc.into Bayer HealthCare Pharmaceuticals, as part of Bayer's acquisition of Schering AG, Germany, Berlex's former parent company.

5 Apr 2007

Filtering white cells from donor blood before transfusion is much safer for patients

The practice of removing the white cells from blood is called leukoreduction. But despite the recommendations of two national advisory committees in 10 years that voted in favor of all patients in the United States receiving leukoreduced blood, ("universal leukoreduction"), the practice is still not wholly supported in the medical community, nor recommended by the Food and Drug Administration. Part of the reason is fear of increased cost.

3 Apr 2007

Screening key to early detection of colorectal cancers

Studies show that only half of the people who are at risk of colon and rectal cancers are getting screened regularly.

21 Mar 2007

Health disparities in prostate cancer care

Decreasing the rates of prostate cancer among black men may require improving access to routine health care, rather than increased education about the disease, a study from the University of North Carolina at Chapel Hill School of Medicine suggests.

12 Mar 2007

Life expectancy doubled for advanced prostate cancer patients

After being diagnosed with aggressive prostate cancer, many men are told that their disease is untreatable and that less aggressive treatment is best.

11 Mar 2007

Tangerine tomatoes boost disease-fighting antioxidants in blood

Deep red tomatoes get their rich color from lycopene, a disease-fighting antioxidant. A new study, however, suggests that a special variety of orange-colored tomatoes provide a different form of lycopene, one that our bodies may more readily use.

28 Feb 2007

Link between growth of blood vessels critical to spread of cancer and copper in our bodies

Growing new blood vessels from existing ones - a process called angiogenesis - is important in growth, development and wound healing. But it also enables the spread of tumors throughout the body, so researchers have been scrambling for ways to stop angiogenesis in the fight against cancer.

28 Feb 2007

Financial interest of drug industry influences research results

According to the latest research breast cancer studies funded by drug companies are more likely to come up with positive findings than those without pharmaceutical industry backing.

26 Feb 2007